Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease

por Hirotaka Saito, Kenichi Tanaka, Tsuyoshi Iwasaki, Akira Oda, Shuhei Watanabe, Makoto Kanno, Hiroshi Kimura, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama
Publicado 2021